Related Experiment Videos
Airway remodeling and long-term decline in lung function in asthma
Nick H T Ten Hacken1, Dirkje S Postma, Wim Timens
1Department of Pulmonology, University Hospital Groningen, The Netherlands. N.H.T.Ten.Hacken@int.azg.nl
Current Opinion in Pulmonary Medicine
|December 12, 2002
Summary
Asthma progression involves airway inflammation, leading to worse symptoms and lung function decline. New research explores factors like interleukin-13 and mast cells in airway remodeling.
Area of Science:
- Pulmonology and immunology research.
- Focus on respiratory diseases and airway inflammation.
Background:
- Asthma is a complex condition characterized by progressive airway obstruction.
- Ongoing airway inflammation is linked to increased airway hyperresponsiveness, reduced lung function, and accelerated decline in forced expiratory volume in 1 second (FEV1).
Purpose of the Study:
- To elucidate the contributing factors and precise relationship between airway inflammation and airway remodeling in asthma.
- To highlight recent advancements in understanding asthma pathogenesis.
Main Methods:
- Review of recent scientific findings and literature.
- Exploration of key molecular and cellular pathways involved in asthma.
Main Results:
- Recent research points to the potential role of interleukin-13 (IL-13) in asthma progression.
- The epithelial-mesenchymal trophic unit (EMTU) is an area of ongoing investigation.
- Degranulated mast cells within bronchial smooth muscle bundles have been identified.
Conclusions:
- Further research is needed to fully understand the interplay between airway inflammation and remodeling in asthma.
- Interleukin-13, EMTU, and mast cell presence are critical areas for future asthma research.